The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 2 rounds in the feed, most often in Biotech.
Corporate venture armabbvie.comRounds from 2016-09-21 to 2018-08-10
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Artios Pharma Artios is a clinical-stage oncology company developing new medicines targeting DNA damage response pathways in cancer for patients with limited treatment options. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $84M | 2018-08-10 | [ PART ] |
Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $33.2M |
| 2016-09-21 |
| [ PART ] |